key: cord-0787364-gucbc5jz
authors: Huang, Ke-Xin; He, Cheng; Yang, Yan-Li; Huang, Di; Jiang, Zhi-Xia; Li, Bang-Guo; Liu, Heng
title: Positive reverse transcription-polymerase chain reaction assay results in patients recovered from COVID-19: Report of two cases
date: 2021-04-26
journal: World J Clin Cases
DOI: 10.12998/wjcc.v9.i12.2816
sha: 24d66f20e7e937b8f82e5e34ec5ce3a3b497b513
doc_id: 787364
cord_uid: gucbc5jz

BACKGROUND: Coronavirus disease 2019 (COVID-19) has spread around the globe. On February 28, 2020, the World Health Organization adjusted the risk of spread and impact of COVID-19 to “very high” at the global level. Studies have mainly focused on the etiology, epidemiology, and treatment of COVID-19 to limit further spread and the negative impact of the disease, while less attention has been devoted to the follow-up and reexamination of patients who recovered from COVID-19 or were released from quarantine. CASE SUMMARY: This study reports two cases where patients who had negative reverse transcription-polymerase chain reaction (RT-PCR) test results and met the criteria for discharge subsequently had positive RT-PCR test results. The clinical manifestations and computed tomography (CT) findings of these patients were examined. The conversion of RT-PCR test results in these two patients may be related to false-negative and false-positive outcomes of the test. CT images helped track improvement of pulmonary lesions. CONCLUSION: The timing of discharge of COVID-19 patients should be determined by comprehensive analysis of CT images and RT-PCR test results.

open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See 

Since the coronavirus disease 2019 (COVID-19) outbreak, the World Health Organization (WHO) raised the risk level of the global spread of COVID-19 to "very high" on February 28, 2020. As of December 13, 2020, more than 70 million confirmed cases have been reported worldwide. COVID-19 has resulted in more deaths than severe acute respiratory syndrome (SARS) and Middle East respiratory syndrome combined, despite having a lower-case fatality rate [1] .

Published studies have mainly focused on the etiology, epidemiology, and treatment of COVID-19 to limit further spread and the negative impact of the disease, while less attention has been devoted to the follow-up and reexamination of patients who recovered from COVID-19 or were released from quarantine. We herein report two patients whose reverse transcription-polymerase chain reaction (RT-PCR) assay results were positive after they had recovered from COVID-19.

hospitalization. He was treated with conventional antiviral therapy including antivirals (lopinavir and interferon), an immune modulator (thymosin), and methylprednisolone. Moreover, the patient also received traditional Chinese medicine treatment.

Case 1: During hospitalization, the patient's body temperature normalized, but she developed episodes of vomiting. After antiviral and supportive treatment, the patient was discharged from the hospital. Before discharge, two RT-PCR tests with samples taken 24 h apart were negative, and a chest CT scan showed a decrease in the size and extent of pulmonary opacities ( Figure 2 ). The patient remained asymptomatic during the subsequent 14 d of isolation and observation at a rehabilitation center. After the isolation period, she had a repeat RT-PCR assay that was positive. Therefore, she was re-admitted to the hospital where she had two additional RT-PCR tests over the next week, one negative and one positive. Her body temperature stayed normal. The laboratory tests showed a normal leukocyte count (4.4 × 10 9 /L), normal percentage of lymphocytes (36.5%), and normal percentage of neutrophils (55%). Chest CT showed near resolution of linear and ground-glass opacities (GGO) in both lungs ( Figure 3 ).

The patient's symptoms gradually improved during hospitalization. Two throat swab RT-PCR assays performed 24 h apart were negative. Chest CT showed decreased pulmonary opacities. He was discharged on February 11, 2020. His throat swab test was positive after 14 d of isolation and observation following discharge, despite a lack of clinical symptoms. He was re-admitted to the hospital where he had three repeat RT-PCR tests performed over the next 8 d, one positive and two negative ( Figure 1) . Laboratory examination showed a normal leukocyte count (4.7 × 10 9 /L), normal C-reactive protein (2 mg/L), and normal erythrocyte sedimentation rate (5 mm/h).

Both patients met the criteria for recovery of COVID-19, so they were allowed to be discharged from the hospital; nevertheless, both had positive RT-PCR test results 14 d later. According to the COVID-19 diagnosis and treatment plan (trial version 6) published by the National Health Commission of China, patients should meet the following criteria simultaneously for hospital discharge: (1) Normal body temperature lasting more than 3 d; (2) resolved respiratory symptoms; (3) pulmonary imaging showing significant improvement in acute exudative lesions; and (4) two consecutive negative nucleic acid tests for respiratory pathogens (sampling interval of at least 1 d). These results raise additional questions such as imperfect sampling, finite sensitivity of virus detection, intermittency of virus shedding, and reinfection or recurrence. The current criteria for hospital discharge or discontinuation of quarantine might need to be reevaluated [2] .

The accuracy of the RT-PCR assay was dependent on both the adequacy of the collected sample and the accuracy of the test kit. A study on the correlation of chest CT and RT-PCR tests showed that the positive rates of RT-PCR assays and chest CTs were 59% and 88%, respectively, for patients with suspected COVID-19 [3] . The sample for RT-PCR can be collected by various methods including nasopharyngeal or throat swabs or bronchoscopy. Throat swab collection is more convenient than other methods and was used to collect samples prior to discharge in both patients. It has been speculated that the main target tissue of COVID-19 is pulmonary alveoli [4] . Therefore, the concentration of the virus in the throat may not be sufficient for detection [5] . Another study confirmed the presence of SARS-CoV-2 RNA in extra-pulmonary sites including blood and anal swabs, and the concentration of viral RNA in the anal swab was higher than that in the blood in some patients, suggesting that the virus might replicate in the digestive tract [6] . When the throat swabs became negative, the virus might still have been present at extra-pulmonary sites. Moreover, several patients infected with SARS-CoV-2 only presented with gastrointestinal symptoms including diarrhea, persistent nausea, and vomiting [7] . We observed similar gastrointestinal symptoms with respect to case 1. On the other hand, a more recent study reports the persistence of the virus for more than 60 d with a median duration of RT-PCR

Ten days after symptom onset, computed tomography (CT) showed patchy bilateral subpleural ground-glass opacities (GGO); C and D: Twelve days after symptom onset, the subpleural GGO decreased and evolved into linear opacities; E and F: Seventeen days after symptom onset, there was a further reduction of GGO and predominance of linear opacities; G and H: CT performed 38 d after symptom onset showed near complete resolution of pulmonary opacities (orange arrow, G). positivity of more than 30 d [8] . Therefore, we surmise that it is possible that the RT-PCR tests prior to discharge were all false negatives. RT-PCR assays are highly sensitive; however, sensitive detection is associated with false-positive results [9] . Both patients had one subsequent positive RT-PCR test after rehospitalization. The possibility of two false-positive results in the tests was low but the durability of the SARS-CoV-2 antibody response is not completely understood at this point, so such a possibility cannot be excluded. Some studies have reported that viral shedding has been observed in some cases for up to 3 mo. This might be an important cause of false-positive RT-PCR results [10] . On the other hand, the fact that we detected SARS-CoV-2 RNA in the upper respiratory tract secretions and other bodily fluids does not necessarily imply that the virus was viable.

Some guidelines from the Centers for Disease Control and Prevention did acknowledge that, in view of the occurrence of false-positive test results, relying on negative RT-PCR results to clear a patient from transmission-based precautions would not be reliable. They extended the timeframe for stopping preventive measures for discharged patients [11] . This requisite also implies that more negative RT-PCR results may be needed for patients to be discharged or to be released from isolation. However, it remains to be determined if patients with a viral concentration too low for detection by throat swab pose a threat to transmit the disease once discharged into the community. These findings warrant further studies into the potential of viral persistence in the bodily fluid specimens of discharged patients. Being able to identify those with false-positive RT-PCR test results and those who are asymptomatic [5] will be meaningful for further COVID-19 research.

The WHO has recommended adopting chest X-rays for the diagnosis and therapeutic planning of the patients with suspected or confirmed COVID-19 based on the following factors: (1) CT imaging normally has a lower specificity compared to RT-PCR; (2) chest radiography is associated with lower radiation doses than CT scanner;

(3) it is easier to repeat X-rays sequentially for monitoring disease progression; and (4) the portable equipment at the point of care can be easily used to increase efficiency. However, according to common practices, literature reports, and Cochrane review, we found that chest X-rays have no advantages over the CT chest imaging, given that in the initial assessment of COVID-19, most studies focused on detecting pneumonia rather than viral pneumonia by X-rays [12, 13] . In addition, CT is more sensitive and more commonly used than X-rays, with a 94% sensitivity [14] for COVID-19 diagnosis. Furthermore, in our daily practice, an additional CT machine has also been arranged to examine patients with a high fever and patients suspected of having COVID-19. Some medical institutions have even taken urgent actions to develop mobile CT scanners for dedicated use. These arrangements help to reduce the risk of crossinfections from patients undergoing imaging examinations.

The CT image of the first patient during initial hospitalization showed that acute GGO and consolidation improved and evolved into a linear band-like appearance ( Figure 2 ). The CT changes met the discharge requirements. When the patient was rehospitalized, CT demonstrated further resolution of pulmonary opacities, and there were no new lesions or residual fibrosis found in the lung tissue ( Figure 2 ) [15] . Similarly, the CT images of patient 2 also showed near complete absence of CT abnormalities when he was re-hospitalized ( Figure 3) . Previous studies have shown that while chest CT signs of improvement began at approximately 14 d after the onset of initial symptoms, the absorption stage lasted for more than 26 d [16] . From the CT images, we can observe the continuous process of gradual absorption of pulmonary lesions, and there were no new lesions. Low-dose CT screening has steadily gained popularity for routine physical examination, and gradual resolution of pulmonary lesions can be observed on serial CT images.

In conclusion, the recovery of patients with COVID-19 tends to be a lengthy process. Gradual resolution of pulmonary lesions can be observed on serial CT images. Given the reported false-negative and false-positive rates of RT-PCR, further refinement of discharge criteria might be necessary. More than two negative RT-PCR test results prior to termination of isolation can potentially reduce the risk of a subsequent

Coronavirus covid-19 has killed more people than SARS and MERS combined, despite lower case fatality rate

Positive RT-PCR Test Results in Patients Recovered From COVID-19

Correlation of Chest CT and RT-PCR Testing for Coronavirus Disease 2019 (COVID-19) in China: A Report of 1014 Cases

Pathological findings of COVID-19 associated with acute respiratory distress syndrome

A retrospective analysis of the epidemiology, clinical manifestations, and imaging characteristics of familial clusteronset COVID-19

Detectable 2019-nCoV viral RNA in blood is a strong indicator for the further clinical severity

SARS-CoV-2 induced diarrhoea as onset symptom in patient with COVID-19

Duration of Viral Shedding of Discharged Patients With Severe COVID-19

Analytical performance of norovirus real-time RT-PCR detection protocols in Canadian laboratories

Towards an accurate and systematic characterisation of persistently asymptomatic infection with SARS-CoV-2

Discontinuation of Transmission-Based Precautions and Disposition of Patients with COVID-19 in Healthcare Settings (Interim Guidance)

Clinical and thin-section CT features of patients with the COVID-19 in Wuhan (in Chinese)

Deep learning-based model for detecting 2019 novel coronavirus pneumonia on high-resolution computed tomography

Diagnostic Performance of CT and Reverse Transcriptase Polymerase Chain Reaction for Coronavirus Disease 2019: A Meta-Analysis

From the radiologic pathology archives: organization and fibrosis as a response to lung injury in diffuse alveolar damage, organizing pneumonia, and acute fibrinous and organizing pneumonia

Time Course of Lung Changes at Chest CT during Recovery from Coronavirus Disease 2019 (COVID-19)